Syndecan-4 mediates macrophage uptake of group V secretory phospholipase A2-modified LDL.
about
Multimolecular signaling complexes enable Syk-mediated signaling of CD36 internalizationMacrophages create an acidic extracellular hydrolytic compartment to digest aggregated lipoproteins.Bioactive products generated by group V sPLA(2) hydrolysis of LDL activate macrophages to secrete pro-inflammatory cytokines.Contribution of syndecan-4 genetic variants to hypertension, the TAMRISK studyReducing macrophage proteoglycan sulfation increases atherosclerosis and obesity through enhanced type I interferon signaling.Group X secretory phospholipase A2 enhances TLR4 signaling in macrophagesHeparan sulfate proteoglycans.How an artery heals.Molecular mediators for raft-dependent endocytosis of syndecan-1, a highly conserved, multifunctional receptor.Lipoprotein accumulation in macrophages via toll-like receptor-4-dependent fluid phase uptake.The capacity of group V sPLA2 to increase atherogenicity of ApoE-/- and LDLR-/- mouse LDL in vitro predicts its atherogenic role in vivo.Syndecan-4 as a biomarker to predict clinical outcome for glioblastoma multiforme treated with WT1 peptide vaccine.Acidification of the intimal fluid: the perfect storm for atherogenesisSyndesome Therapeutics for Enhancing Diabetic Wound HealingAggregated LDL in contact with macrophages induces local increases in free cholesterol levels that regulate local actin polymerization.Syndecan-4: a novel regulator of collagen synthesis and deposition in the pressure-overloaded myocardium.
P2860
Q28589223-AFEC97EE-4543-4E15-80E5-7E73668396DDQ30492073-CF60F41E-BFA9-4429-8A04-6FE44A12DCC1Q33771533-5C9DE3D8-1682-4F5C-BD5A-C213B13791A0Q34586808-581B0241-BD08-4669-8417-5C881F001216Q34625670-800EA221-22A4-422A-9CC7-9858F150D289Q35058961-FC197CC9-12B7-4C73-89A1-27608A152A57Q35059448-AC366418-4AB4-47F0-BAD8-72AC3C60117EQ36329387-60011769-94F2-40DA-8D64-D6D62A01C295Q36850197-AF4F44B1-12ED-4C8C-8CDE-37C3AF52FDEAQ37340933-384FAADE-2ED6-430B-81E9-BF49922AC3F1Q37435082-E822DD0B-8A89-42ED-BB50-5BB16BABC7D8Q37591458-7419A2D2-AB3B-4B46-ABF1-ACAEBA6215F1Q38271332-6379F4BB-1255-4993-8E45-3219AE018A82Q41421987-E8895D6F-C689-4C8C-B6D3-8F4991558E1EQ42574419-3787F4A7-D665-4FE5-ADE1-261FAB097B43Q48088929-F2A78DA4-F756-477B-864C-8B2420BFD096
P2860
Syndecan-4 mediates macrophage uptake of group V secretory phospholipase A2-modified LDL.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Syndecan-4 mediates macrophage uptake of group V secretory phospholipase A2-modified LDL.
@en
Syndecan-4 mediates macrophage uptake of group V secretory phospholipase A2-modified LDL.
@nl
type
label
Syndecan-4 mediates macrophage uptake of group V secretory phospholipase A2-modified LDL.
@en
Syndecan-4 mediates macrophage uptake of group V secretory phospholipase A2-modified LDL.
@nl
prefLabel
Syndecan-4 mediates macrophage uptake of group V secretory phospholipase A2-modified LDL.
@en
Syndecan-4 mediates macrophage uptake of group V secretory phospholipase A2-modified LDL.
@nl
P2093
P2860
P1476
Syndecan-4 mediates macrophage uptake of group V secretory phospholipase A2-modified LDL.
@en
P2093
Boris B Boyanovsky
Deneys R van der Westhuyzen
Michael Simons
Nancy R Webb
Preetha Shridas
P2860
P304
P356
10.1194/JLR.M800450-JLR200
P577
2008-12-03T00:00:00Z